Results 221 to 230 of about 1,184,339 (384)

Lipolysis Produces Changes in the Immunoreactivity and Cell Reactivity of Very Low Density Lipoproteins [PDF]

, 1979
Gustav Schonfeld, Wolfgang Patsch, Barbara Pfleger, Joseph L. Witztum, S W Weidman   +4 more
openalex   +1 more source

Beneficial influence of low-density lipoprotein cholesterol on the endothelium in relation to endothelial repair. [PDF]

Environ Health Prev Med
Shimizu Y, Kawashiri SY, Yamanashi H, Nakamichi S, Hayashida N, Nagata Y, Maeda T.   +6 more
europepmc   +1 more source

High-density and low-density lipoproteins and prevalence of vascular disease in diabetes mellitus. [PDF]

, 1978
J.P.D. Reckless, D. J. Betteridge, Ping-Ping Wu, B. Payne, D. J. Galton   +4 more
openalex   +1 more source

Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.

Molecules and Cells, 1998
L. Gu, Y. Okada, S. Clinton, C. Gerard, G. Sukhova, P. Libby, B. Rollins   +6 more
semanticscholar   +1 more source

Clinical significance of small dense low-density lipoprotein cholesterol measurement in type 2 diabetes. [PDF]

J Diabetes Investig
Hirano T.
europepmc   +1 more source

Atherosclerotic Plaque Progression and Incident Cardiovascular Events in a 10‐Year Prospective Study of Patients With Systemic Lupus Erythematosus: The Impact of Persistent Cardiovascular Risk Factor Target Attainment and Sustained DORIS Remission

Arthritis &Rheumatology, EarlyView.
Objective Cardiovascular disease (CVD) is a leading cause of death in individuals with systemic lupus erythematosus (SLE). We assessed atherosclerotic plaque progression and incident cardiovascular events in patients with SLE over a 10‐year follow‐up.
Nikolaos Papazoglou, Petros P. Sfikakis, Maria G. Tektonidou   +2 more
wiley   +1 more source

In vitro production of human plasma low density lipoprotein-like particles. A model for very low density lipoprotein catabolism.

, 1979
Richard J. Deckelbaum, S Eisenberg, M Fainaru, Yechezkel Barenholz, Thomas Olivecrona   +4 more
openalex   +1 more source

Control of 3-Hydroxy-3-Methylglutaryl-CoA Reductase Activity in Cultured Human Fibroblasts by Very Low Density Lipoproteins of Subjects with Hypertriglyceridemia [PDF]

, 1978
Sandra H. Gianturco, Antonio M. Gotto, Richard L. Jackson, Josef R. Patsch, Harley D. Sybers, O. David Taunton, Daniel Yeshurun, Louis C. Smith   +7 more
openalex   +1 more source

Oxidized Low-Density Lipoprotein and Its Role in Immunometabolism. [PDF]

Int J Mol Sci
Mosalmanzadeh N, Pence BD.
europepmc   +1 more source

Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with Janus kinase inhibitors compared to biologic disease‐modifying antirheumatic drugs: data from an international collaboration of registries (the "JAK‐pot" study)

Arthritis &Rheumatology, Accepted Article.
Objective To assess the incidence of major adverse cardiovascular events (MACE) in RA patients treated with JAKi, TNF‐inhibitors (TNFi) or biologic Disease‐Modifying Anti‐Rheumatic Drugs with other modes of action (bDMARD‐OMA) in a multi‐country, real‐world population.
Romain Aymon, Denis Mongin, Romain Guemara, Zubeyir Salis, Johan Askling, Denis Choquette, Catalin Codreanu, Daniela Di Giuseppe, Irini Flouri, Doreen Huschek, Kimme L Hyrich, Florenzo Iannone, Tore K Kvien, Burkhard F Leeb, Dan Nordström, Lucia Otero‐Varela, Karel Pavelka, Manuel Pombo‐Suarez, Ana Rodrigues, Ziga Rotar, Prodromos Sidiropoulos, Sella A Provan, Anja Strangfeld, Trokovic Nina, Jakub Zavada, Lianne Kearsley‐Fleet, Delphine S Courvoisier, Axel Finckh, Kim Lauper   +28 more
wiley   +1 more source